Abstract
Clinical translation of scientific discoveries from bench to bedside is typically a challenging process with sporadic progress along its trajectory. Analyzing R&D can provide key intelligence on advancing biomedical innovation in target domains of interest. In this study, we explore the feasibility of using a streamlined tech mining approach for identification of translational indicators and potential opportunities, using observable markers extracted from selected research literature. We apply this strategy to analyze a set of 23,982 PubMed records that involved gold nanostructures (GNSs) research. Nine indicators are generated to assess what different GNSs research activities had achieved and to predict where GNSs research will likely go. We believe such analysis can provide useful translation intelligence for researchers, funding agencies, and pharmaceutical and biotech companies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
